These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8492955)

  • 21. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity.
    Bozzette SA; Santangelo J; Villasana D; Fraser A; Wright B; Jacobsen C; Hayden E; Schnack J; Spector SA; Richman DD
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):851-5. PubMed ID: 1654410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zidovudine update: 1990.
    Morse GD; Lechner JL; Santora JA; Rozek SL
    DICP; 1990; 24(7-8):754-60. PubMed ID: 2197818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
    Rathbun RC; Martin ES
    Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zidovudine--the first year of experience.
    Williams I; Gabriel G; Cohen H; Williams P; Tedder RS; Machin S; Weller IV
    J Infect; 1989 Jan; 18 Suppl 1():23-31. PubMed ID: 2915140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia.
    Rarick MU; Loureiro C; Groshen S; Sullivan-Halley J; Gill PS; Bernstein-Singer M; Levine AM
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):593-7. PubMed ID: 1673713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 34. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
    Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC
    Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB; Drucker RP; McKinney RE; Wilfert CM
    J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract]   [Full Text] [Related]  

  • 37. Human immunodeficiency virus wasting syndrome may represent a treatable myopathy.
    Simpson DM; Bender AN; Farraye J; Mendelson SG; Wolfe DE
    Neurology; 1990 Mar; 40(3 Pt 1):535-8. PubMed ID: 2314598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 39. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L
    J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.